On January 4, 2023, Mantra Bio, Inc. closed the transaction. The company has received $9,000,000 in its second and final tranche, bringing the total funds raised in the transaction to $39,131,370. The transaction included participation from new investor, Samsung Securities Co., Ltd., and other investors, 8VC, Viking Global Investors LP, Illumina Accelerator Program, BoxGroup Services, LLC, Allen & Company of Florida, LLC.